PSILX vs. ENVB

Last updated Jun 16, 2026

PSILX (T. Rowe Price Spectrum International Equity Fund) is Foreign Large Cap Equities fund managed by T. Rowe Price, while ENVB (Enveric Biosciences Inc) is a stock. Over the past 10 years, PSILX returned 8.88%/yr vs -74.86%/yr for ENVB. At a 0.19 correlation, their price movements are largely independent.

Performance

PSILX vs. ENVB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Spectrum International Equity Fund (PSILX) and Enveric Biosciences Inc (ENVB). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PSILX achieves a 12.26% return, which is significantly higher than ENVB's -59.23% return. Over the past 10 years, PSILX has outperformed ENVB with an annualized return of 8.88%, while ENVB has yielded a comparatively lower -74.86% annualized return.

PSILX

• 1D: 0.46%
• 1M: 3.76%
• YTD: 12.26%
• 6M: 14.02%
• 1Y: 27.05%
• 3Y*: 16.34%
• 5Y*: 6.27%
• 10Y*: 8.88%

ENVB

• 1D: -3.27%
• 1M: -34.22%
• YTD: -59.23%
• 6M: -72.39%
• 1Y: -89.81%
• 3Y*: -87.52%
• 5Y*: -85.10%
• 10Y*: -74.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PSILX vs. ENVB - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
PSILX T. Rowe Price Spectrum International Equity Fund	12.26%	30.30%	4.28%	13.83%	-18.04%	5.00%	13.94%	25.00%	-14.83%	26.79%
ENVB Enveric Biosciences Inc	-59.23%	-94.37%	-72.43%	-37.50%	-95.53%	-37.16%	-34.51%	-48.17%	-94.37%	-52.38%

Correlation

The correlation between PSILX and ENVB is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (5Y) Calculated over the trailing 5-year period	0.24
Correlation (10Y) Calculated over the trailing 10-year period	0.20
Correlation (All Time) Calculated using the full available price history since Jan 4, 2016	0.19

Return for Risk

PSILX vs. ENVB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSILX

PSILX Risk / Return Rank: 40
PSILX Sharpe Ratio Rank: 40
PSILX Sortino Ratio Rank: 39
PSILX Omega Ratio Rank: 43
PSILX Calmar Ratio Rank: 37
PSILX Martin Ratio Rank: 40

ENVB

ENVB Risk / Return Rank: 11
ENVB Sharpe Ratio Rank: 19
ENVB Sortino Ratio Rank: 12
ENVB Omega Ratio Rank: 12
ENVB Calmar Ratio Rank: 2
ENVB Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PSILX vs. ENVB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Spectrum International Equity Fund (PSILX) and Enveric Biosciences Inc (ENVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PSILX	ENVB	Difference
Sharpe ratio: Return per unit of total volatility	1.59	-0.51	+2.10
Sortino ratio: Return per unit of downside risk	2.25	-1.01	+3.26
Omega ratio: Gain probability vs. loss probability	1.30	0.87	+0.43
Calmar ratio: Return relative to maximum drawdown	2.04	-0.98	+3.02
Martin ratio: Return relative to average drawdown	7.72	-1.34	+9.06

PSILX vs. ENVB - Sharpe Ratio Comparison

The current PSILX Sharpe Ratio is 1.59, which is higher than the ENVB Sharpe Ratio of -0.51. The chart below compares the historical Sharpe Ratios of PSILX and ENVB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

PSILX vs. ENVB - Drawdown Comparison

The maximum PSILX drawdown since its inception was -61.38%, smaller than the maximum ENVB drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for PSILX and ENVB.

Drawdown Indicators

	PSILX	ENVB	Difference
Max Drawdown Largest peak-to-trough decline	-61.38%	-100.00%	+38.62%
Max Drawdown (1Y) Largest decline over 1 year	-12.72%	-91.49%	+78.77%
Max Drawdown (3Y) Largest decline over 3 years	-13.70%	-99.81%	+86.11%
Max Drawdown (5Y) Largest decline over 5 years	-33.13%	-100.00%	+66.87%
Max Drawdown (10Y) Largest decline over 10 years	-33.33%	-100.00%	+66.67%
Current Drawdown Current decline from peak	-1.66%	-100.00%	+98.34%
Average Drawdown Average peak-to-trough decline	-14.05%	-86.07%	+72.02%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.32%	66.73%	-63.41%

Volatility

PSILX vs. ENVB - Volatility Comparison

The current volatility for T. Rowe Price Spectrum International Equity Fund (PSILX) is 6.70%, while Enveric Biosciences Inc (ENVB) has a volatility of 21.07%. This indicates that PSILX experiences smaller price fluctuations and is considered to be less risky than ENVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PSILX	ENVB	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.70%	21.07%	-14.37%
Volatility (6M) Calculated over the trailing 6-month period	14.03%	105.59%	-91.56%
Volatility (1Y) Calculated over the trailing 1-year period	16.33%	175.01%	-158.68%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.94%	155.96%	-140.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.28%	164.65%	-148.37%

Dividends

PSILX vs. ENVB - Dividend Comparison

PSILX's dividend yield for the trailing twelve months is around 4.83%, while ENVB has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ENVB Enveric Biosciences Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PSILX T. Rowe Price Spectrum International Equity Fund	4.83%	5.42%	2.04%	1.88%	6.67%	3.49%	0.88%	3.49%	6.69%	0.58%	0.17%	0.08%

Frequently Asked Questions

Can I hold both PSILX and ENVB in my portfolio?

PSILX and ENVB have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PSILX or ENVB?

ENVB has higher volatility (21.07%) compared to PSILX (6.70%). In terms of maximum drawdown, PSILX dropped -61.38% vs ENVB's -100.00%.

Which has better risk-adjusted returns?

PSILX currently has the higher Sharpe Ratio (1.59 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.